Loss of SMPD4 Causes a Developmental Disorder Characterized by Microcephaly and Congenital Arthrogryposis

Area of Science:

• Molecular Biology
• Genetics
• Developmental Biology

Background:

• Sphingomyelinases are enzymes that produce ceramide, a crucial second messenger in cellular signaling.
• Ceramide is involved in regulating cell proliferation, differentiation, and apoptosis.
• Disruptions in sphingolipid metabolism can lead to severe developmental disorders.

Purpose of the Study:

• To investigate the genetic basis of a severe developmental disorder characterized by microcephaly and early demise.
• To elucidate the function of SMPD4 (neutral sphingomyelinase-3) in human development and cellular homeostasis.

Main Methods:

• Genomic analysis of affected individuals from 12 unrelated families to identify causative variants.
• Expression and localization studies of human SMPD4, including proteomics for interaction partners.
• Analysis of patient-derived fibroblasts to assess cellular phenotypes, including ER structure, autophagy, apoptosis, and cell cycle progression.

Main Results:

• Bi-allelic loss-of-function variants in SMPD4 were identified as the cause of the observed severe developmental phenotype.
• SMPD4 localizes to the outer nuclear envelope and ER, interacting with nuclear pore complex proteins.
• Patient fibroblasts exhibit ER abnormalities, increased susceptibility to apoptosis, and delayed cell cycle progression upon SMPD4 knockdown.

Conclusions:

• SMPD4 is essential for linking membrane sphingolipid homeostasis to cell fate determination.
• The enzyme regulates cross-talk between the ER and the outer nuclear envelope.
• Loss of SMPD4 function reveals a critical pathogenic mechanism underlying microcephaly and related developmental defects.